Exploit: Ransomware
eResearch Technology: Medical Research Technology Provider
Risk to Business: 1.330 = Extreme In a disturbing turn of events, eResearch Technology was severely impacted by a ransomware attack that slowed down progress on COVID-19 vaccine and treatment research. The provider of technology that enables clinical trials and data sharing at organizations including AstraZeneca, Oxford University, and Bristol Myers Squibb, reported that its employees could not access many systems. That in turn affected clinical trials in progress as researchers were forced to track patient data manually using pen and paper. Systems were down for several days for repair.
Individual Risk: No personal data has been reported as impacted in this incident.
Customers Impacted: Unknown
How it Could Affect Your Customers’ Business: Ransomware is a devastating weapon that bad actors are using to shut down essential services and attacks in the medical sector have been escalating – just last week healthcare giant Universal Health Services was walloped by ransomware and is still recovering.
Risk Levels:
1 - 1.5 = Extreme Risk
1.51 - 2.49 = Severe Risk
2.5 - 3 = Moderate Risk
*The risk score is calculated using a formula that considers a wide range of factors related to the assessed breach.
